JANE STREET GROUP, LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is G8807B906. A total of 4 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q4 2022$1,184,832
+330.8%
105,600
+247.4%
0.00%
Q2 2022$275,00030,4000.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 7,400$171,0000.00%
SIMPLEX TRADING, LLC 51$117,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of THERAVANCE BIOPHARMA INC shareholders